JP2021523744A5 - - Google Patents
Info
- Publication number
- JP2021523744A5 JP2021523744A5 JP2021514483A JP2021514483A JP2021523744A5 JP 2021523744 A5 JP2021523744 A5 JP 2021523744A5 JP 2021514483 A JP2021514483 A JP 2021514483A JP 2021514483 A JP2021514483 A JP 2021514483A JP 2021523744 A5 JP2021523744 A5 JP 2021523744A5
- Authority
- JP
- Japan
- Prior art keywords
- signature
- expression levels
- stroke
- biomarkers
- subject
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024051056A JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305600 | 2018-05-16 | ||
| EP18305600.1 | 2018-05-16 | ||
| PCT/EP2019/062653 WO2019219831A1 (en) | 2018-05-16 | 2019-05-16 | Blood biomarkers of stroke |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024051056A Division JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021523744A JP2021523744A (ja) | 2021-09-09 |
| JP2021523744A5 true JP2021523744A5 (https=) | 2022-05-23 |
| JPWO2019219831A5 JPWO2019219831A5 (https=) | 2022-05-23 |
| JP7463351B2 JP7463351B2 (ja) | 2024-04-08 |
Family
ID=62386311
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514483A Active JP7463351B2 (ja) | 2018-05-16 | 2019-05-16 | 脳卒中の血液バイオマーカー |
| JP2024051056A Pending JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024051056A Pending JP2024075761A (ja) | 2018-05-16 | 2024-03-27 | 脳卒中の血液バイオマーカー |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12247257B2 (https=) |
| EP (1) | EP3794355A1 (https=) |
| JP (2) | JP7463351B2 (https=) |
| KR (1) | KR20210049026A (https=) |
| CN (1) | CN112424609A (https=) |
| AU (1) | AU2019270404B2 (https=) |
| BR (1) | BR112020023259A2 (https=) |
| CA (1) | CA3100171A1 (https=) |
| IL (1) | IL278666B2 (https=) |
| MA (1) | MA52617A (https=) |
| MX (1) | MX2020012297A (https=) |
| SG (1) | SG11202011369VA (https=) |
| WO (1) | WO2019219831A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220093267A1 (en) * | 2019-01-22 | 2022-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Noninvasive real-time patient-specific assessment of stroke severity |
| CN114107487B (zh) * | 2021-12-23 | 2024-01-09 | 太原市精神病医院 | 一种可用于诊断脑卒中的产品 |
| JP2023111774A (ja) * | 2022-01-31 | 2023-08-10 | 国立研究開発法人国立循環器病研究センター | 再灌流療法の適用を決定するバイオマーカー |
| CN116705296B (zh) * | 2023-06-06 | 2024-09-13 | 中国科学院深圳先进技术研究院 | 一种基于常规mri序列对gbm患者进行风险分层的方法及系统 |
| WO2025151599A1 (en) * | 2024-01-09 | 2025-07-17 | Morehouse School Of Medicine | Rna-based method for stroke assessment and treatment |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| AU2002241520A1 (en) * | 2000-11-28 | 2003-03-03 | University Of Cincinnati | Blood assessment of injury |
| US9005891B2 (en) | 2009-11-10 | 2015-04-14 | Genomic Health, Inc. | Methods for depleting RNA from nucleic acid samples |
| US9410204B2 (en) | 2012-01-07 | 2016-08-09 | The Regents Of The University Of California | Biomarkers for diagnosing ischemia |
| US20150274815A1 (en) * | 2012-09-25 | 2015-10-01 | The United States of America, as represented by the Secretary, Department of Health & Human Servic | Treatment of central nervous system (cns) injury |
| JP2016507235A (ja) * | 2013-02-01 | 2016-03-10 | ウエストバージニア ユニバーシティＷｅｓｔ Ｖｉｒｇｉｎｉａ Ｕｎｉｖｅｒｓｉｔｙ | 脳卒中症状の発症の時点を決定するためのバイオマーカーアルゴリズムおよび方法 |
| US11021750B2 (en) * | 2013-10-13 | 2021-06-01 | The Research Foundation For State University Of Newyork | Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof |
| CN108291330A (zh) * | 2015-07-10 | 2018-07-17 | 西弗吉尼亚大学 | 卒中和卒中严重性的标志物 |
| US20190311789A1 (en) * | 2016-10-03 | 2019-10-10 | West Virginia University | Computer implemented discovery of biomarkers for blood brain barrier disruption |
-
2019
- 2019-05-16 SG SG11202011369VA patent/SG11202011369VA/en unknown
- 2019-05-16 EP EP19723441.2A patent/EP3794355A1/en active Pending
- 2019-05-16 CN CN201980047566.0A patent/CN112424609A/zh active Pending
- 2019-05-16 WO PCT/EP2019/062653 patent/WO2019219831A1/en not_active Ceased
- 2019-05-16 MX MX2020012297A patent/MX2020012297A/es unknown
- 2019-05-16 JP JP2021514483A patent/JP7463351B2/ja active Active
- 2019-05-16 KR KR1020207035973A patent/KR20210049026A/ko not_active Ceased
- 2019-05-16 BR BR112020023259-9A patent/BR112020023259A2/pt unknown
- 2019-05-16 MA MA052617A patent/MA52617A/fr unknown
- 2019-05-16 US US17/054,820 patent/US12247257B2/en active Active
- 2019-05-16 IL IL278666A patent/IL278666B2/en unknown
- 2019-05-16 CA CA3100171A patent/CA3100171A1/en active Pending
- 2019-05-16 AU AU2019270404A patent/AU2019270404B2/en active Active
-
2024
- 2024-03-27 JP JP2024051056A patent/JP2024075761A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523744A5 (https=) | ||
| IL278666B2 (en) | Blood biomarkers of stroke | |
| Robertson et al. | Risk stratification in acute variceal bleeding: Comparison of the AIMS65 score to established upper gastrointestinal bleeding and liver disease severity risk stratification scoring systems in predicting mortality and rebleeding | |
| Christ‐Crain et al. | Use of B‐type natriuretic peptide in the risk stratification of community‐acquired pneumonia | |
| Zheng et al. | Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension | |
| MX2018012580A (es) | Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia. | |
| BR112019004075A2 (pt) | métodos para diagnosticar um indivíduo com suspeita de endometriose, para detectar mirna, para diagnosticar um indivíduo que apresenta sintomas de endometriose ou com suspeita de endometriose, para tratar um indivíduo com endometriose, para diagnosticar e tratar um indivíduo com suspeita de endometriose, para diagnosticar endometriose em um indivíduo, para diagnosticar ou prover um prognóstico para endometriose em um indivíduo e para monitorar uma resposta a um tratamento de endometriose em um indivíduo, e, kit. | |
| RU2016137685A (ru) | Способ диагностики туберкулеза | |
| Pronschinske et al. | Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement | |
| Taneja et al. | Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver | |
| García‐Salas et al. | Interleukin‐6 as a predictor of cardiovascular events in troponin‐negative non‐ST elevation acute coronary syndrome patients | |
| Yeager et al. | Plasma proteomics of differential outcome to long‐term therapy in children with idiopathic pulmonary arterial hypertension | |
| Sinha et al. | Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach | |
| RU2019103403A (ru) | Адреномедуллин для оценки застоя у индивидуума с острой сердечной недостаточностью | |
| Ji et al. | Diagnostic and prognostic value of galectin‐3, serum creatinine, and cystatin C in chronic kidney diseases | |
| JP2021523379A5 (https=) | ||
| Bustamante et al. | Sepsis biomarkers reprofiling to predict stroke-associated infections | |
| Noguchi et al. | Roles of serum fibrinogen α chain‐derived peptides in Alzheimer's disease | |
| Sawicki et al. | Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes | |
| Nishikawa et al. | Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein in chronic hepatitis C | |
| Bonanad et al. | Serum heat shock protein 60 in acute heart failure: a new biomarker? | |
| WANG et al. | Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosis | |
| Barba et al. | Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation | |
| Lim et al. | Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women | |
| JPWO2019219831A5 (https=) |